Uptravi User Reviews & Ratings (Page 2)
Uptravi has an average rating of 5.4 out of 10 from a total of 27 reviews on Drugs.com. 26% of reviewers reported a positive experience, while 33% reported a negative experience.
Reviews for Uptravi
- col...
- Taken for 1 to 6 months
- December 5, 2023
For Pulmonary Arterial Hypertension "I am now at 1000 a day and night, 800 was hard. I was having really bad back pain on my left side, once that subsided, I slowly went up. So far, I've noticed my breathing is better."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Uptravi (selexipag)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (27)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: agents for pulmonary hypertension
- Breastfeeding
- En español
Patient resources
- Uptravi drug information
- Uptravi (Selexipag Intravenous) (Advanced Reading)
- Uptravi (Selexipag Oral) (Advanced Reading)
For Pulmonary Arterial Hypertension "I cannot stand the pain of 400 mcg twice a day, so I'm going to ask my pulmonologist to put me back to 200 mcg twice a day. I'm not willing to live with this pain if I don't have to."